The UCL Technology Fund (UCLTF) Showcase 2022 was held on Wednesday 11th May at the British Museum. UCLTF’s event, sponsored by Google for Startups, brought together UCL academics, spinouts, investors, and the broader technology ecosystem, as presentations from the Fund’s portfolio companies and projects were delivered in person for the first time since the beginning of COVID-19.

Dr Anne Lane (CEO, UCL Business and UCLTF) and Dr Andrew Elder (Partner, AlbionVC and UCLTF) welcomed guests to the Showcase, who then proceeded into the Life Science and the Physical Science auditoriums to hear from some of UCLTF’s portfolio companies; each company spoke about their achievements so far, and plans to continue their success in the future.

On the Life Science stage, we heard from Luke Henry from Quell Therapeutics, and Peter Adamson from Tenpoint Therapeutics. We also heard from Philippa Mills, who outlined the research she is undertaking alongside Haiyan Zhou on the treatment of disorders affecting lysine metabolism, as well as Matteo Rizzi whose work with Kate Oversby-Powell looks at horizontal cell gene therapies. The panel, chaired by UCLTF’s Leigh Brody, and featuring Cassie Doherty (Parkwalk Advisors), Clare Terlouw (LifeArc) and Mary Canning (Epidarex Capital), asked, ‘What does ‘exit’ actually mean in biotech VC and how is this changing?’

Over on the Physical Science stage, Daniel Summerbell from Carbon Re spoke about their mission within the climate tech space, and Alhamza Alnaimi and Ben Steer from Pometry outlined how they describe the past to predict for today and tomorrow, simplifying data transformation through temporal graph analytics in real-time. The panel, chaired by Marina Santilli (UCL Business), and featuring John Cassidy (Kindred Capital VC), John Taysom (Angel Investor), and Manjari Chandran-Ramesh (Amadeus Capital Partners), discussed the ‘Funding landscape for deep tech businesses’. The final two presentations came from Hazy’s Harry Keen, who use synthetic data to conduct sophisticated data analysis, and Odin Vision’s Peter Mountney who discussed their work using AI to improve detection and diagnosis of cancer.

After the presentations, there was an opportunity for the attendees, presenters, and panellists to network with each other, allowing them to engage in discussions about the portfolio companies, their projects, and the future of their technologies.

If you enjoyed our Showcase, or if you missed this year’s and would like to attend in the future, keep an eye out on our socials for more details about next year’s event. Thank you to everyone who attended and participated in some engaging discussions about technology. We look forward to welcoming you again soon at the UCLTF Showcase 2023!

Watch the full highlights of the UCLTF Showcase 2022 in the video below.

• Share